Compare Charles River Laboratories Intl. Inc (CRL) vs Altria Group Inc (MO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Charles River Laboratories Intl. Inc vs Altria Group Inc — how do they compare? Charles River Laboratories Intl. Inc trades at $287.99 (market cap $13.46B), while Altria Group Inc trades at $64.99 (market cap $108.58B). The key difference: Altria Group Inc is far larger — about 8.1× Charles River Laboratories Intl. Inc's market cap, and Altria Group Inc pays a 6.52% dividend while Charles River Laboratories Intl. Inc pays none. Which is the better fit depends on your goals.
| CRL | MO | |
|---|---|---|
Market Cap | $13.46B | $108.58B |
Sector | Health | Consumer Staples |
52-Week High | $282.00 | $74.92 |
52-Week Low | $145.57 | $54.72 |
Enterprise Value | $16.30B | $130.79B |
Dividend Yield | — | 6.52% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Charles River Laboratories Intl. Inc
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Read more on CRL →About Altria Group Inc
Altria comprises Philip Morris USA, U.S. Smokeless Tobacco, John Middleton, Helix Innovations, and Philip Morris Capital, although the company plans to wind down Philip Morris Capital by the end of 2022. It holds a 10% interest in the world's largest brewer, Anheuser-Busch InBev. Through its tobacco subsidiaries, Altria holds the leading position in cigarettes and smokeless tobacco in the United States and the number-two spot in machine-made cigars. The company's Marlboro brand is the leading cigarette brand in the U.S. with a 43% share in 2020. Altria holds strategic investments in JUUL Labs (35% economic interest) and Cronos (42%).
Read more on MO →
